Vitrolife AB (FRA:VTFN) Beta: 1.0628 (As of Jun. 25, 2026)


FRA:VTFN Vitrolife AB FRA:VTFN
78 GF Score
Price €7.78
GF Value €14.38
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Vitrolife AB Beta?

Vitrolife AB FRA:VTFN +0.45% 78 Beta is 1.0628 as of Jun. 25, 2026. GuruFocus rates FRA:VTFN with a GF Score™ of 78/100 and a GF Value™ of €14.38 (Possible Value Trap). The stock has 6 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-25), Vitrolife AB's Beta is 1.0628.


Vitrolife AB  (FRA:VTFN) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Vitrolife AB Beta Related Terms


Vitrolife AB Beta Historical Data

* Premium members only.

The historical data trend for Vitrolife AB's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vitrolife AB Beta Chart

Vitrolife AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.95 1.59 2.64 -0.20 0.68

Vitrolife AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.39 2.56 1.57 0.68 1.00

FRA:VTFN vs ABT, SYK, MDT: Beta Comparison

For the Medical Devices subindustry, Vitrolife AB's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vitrolife AB Beta vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Vitrolife AB's Beta distribution charts can be found below:

* The bar in red indicates where Vitrolife AB's Beta falls into.


FRA:VTFN
78GF Score
Vitrolife AB FRA:VTFN
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vitrolife AB Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 1.0628 mean?
Vitrolife AB (FRA:VTFN) has a Beta of 1.0628 as of Jun. 25, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Vitrolife AB and its competitors.
Is Vitrolife AB's Beta too high?
Vitrolife AB's current Beta is 1.0628. Overall, Vitrolife AB has a GF Score™ of 78/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Vitrolife AB's Beta compare to ABT and SYK?
Vitrolife AB's Beta of 1.0628 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Medical Devices & Instruments company?
A good Beta depends on the Medical Devices & Instruments industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Vitrolife AB and its competitors. Vitrolife AB's current Beta is 1.0628. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vitrolife AB stock overvalued right now?
Based on GuruFocus' analysis, Vitrolife AB (FRA:VTFN) is currently considered Possible Value Trap. The stock's GF Value™ is €14.38, compared to a current price of €7.78 — trading 45.9% below its estimated fair value. The current Beta is 1.0628. Vitrolife AB's overall GF Score™ is 78/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Vitrolife AB (FRA:VTFN), the current Beta is 1.0628 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vitrolife AB (FRA:VTFN) Overvalued in 2026?

Based on GuruFocus' analysis, Vitrolife AB stock appears to be undervalued. The current stock price of €7.78 is trading 45.9% below its estimated GF Value™ of €14.38. GuruFocus considers Vitrolife AB to be Possible Value Trap.

Key valuation signals for FRA:VTFN:

  • Beta: 1.0628
  • GF Value™: €14.38 vs. price of €7.78 (45.9% below fair value)
  • GF Score™: 78/100 with 6 warning signs

No single metric tells the full story. See the FRA:VTFN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Vitrolife AB Business Description

Address Box 9080, Gothenburg, SWE, 400 92
Vitrolife AB provides medical devices and genetic testing services intended for the reproductive-health market in the field of reproductive health. The company develops, manufactures, and distributes medical devices and provides genetic testing services for IVF clinics and their patients. Its mission is to support IVF clinics (in vitro fertilization) in enhancing their practice as well as the outcome of a patient's fertility treatment, thereby enabling patients to receive support to navigate the complexities of reproductive health through successful outcomes and patient satisfaction. The company has three geographical segments EMEA, Americas and APAC, out of which it derives maximum revenue from EMEA.
78GF Score

Get the complete analysis for FRA:VTFN

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€7.78
Price
€14.38
GF Value